Style | Citing Format |
---|---|
MLA | Varshosaz J, et al.. "Enhanced Solubility, Oral Bioavailability and Anti-Osteoporotic Effects of Raloxifene Hcl in Ovariectomized Rats by Igepal Co-890 Nanomicelles." Pharmaceutical Development and Technology, vol. 24, no. 2, 2019, pp. 133-144. |
APA | Varshosaz J, Ziaei V, Minaiyan M, Jahaniannajafabadi A, Sayedtabatabaei L (2019). Enhanced Solubility, Oral Bioavailability and Anti-Osteoporotic Effects of Raloxifene Hcl in Ovariectomized Rats by Igepal Co-890 Nanomicelles. Pharmaceutical Development and Technology, 24(2), 133-144. |
Chicago | Varshosaz J, Ziaei V, Minaiyan M, Jahaniannajafabadi A, Sayedtabatabaei L. "Enhanced Solubility, Oral Bioavailability and Anti-Osteoporotic Effects of Raloxifene Hcl in Ovariectomized Rats by Igepal Co-890 Nanomicelles." Pharmaceutical Development and Technology 24, no. 2 (2019): 133-144. |
Harvard | Varshosaz J et al. (2019) 'Enhanced Solubility, Oral Bioavailability and Anti-Osteoporotic Effects of Raloxifene Hcl in Ovariectomized Rats by Igepal Co-890 Nanomicelles', Pharmaceutical Development and Technology, 24(2), pp. 133-144. |
Vancouver | Varshosaz J, Ziaei V, Minaiyan M, Jahaniannajafabadi A, Sayedtabatabaei L. Enhanced Solubility, Oral Bioavailability and Anti-Osteoporotic Effects of Raloxifene Hcl in Ovariectomized Rats by Igepal Co-890 Nanomicelles. Pharmaceutical Development and Technology. 2019;24(2):133-144. |
BibTex | @article{ author = {Varshosaz J and Ziaei V and Minaiyan M and Jahaniannajafabadi A and Sayedtabatabaei L}, title = {Enhanced Solubility, Oral Bioavailability and Anti-Osteoporotic Effects of Raloxifene Hcl in Ovariectomized Rats by Igepal Co-890 Nanomicelles}, journal = {Pharmaceutical Development and Technology}, volume = {24}, number = {2}, pages = {133-144}, year = {2019} } |
RIS | TY - JOUR AU - Varshosaz J AU - Ziaei V AU - Minaiyan M AU - Jahaniannajafabadi A AU - Sayedtabatabaei L TI - Enhanced Solubility, Oral Bioavailability and Anti-Osteoporotic Effects of Raloxifene Hcl in Ovariectomized Rats by Igepal Co-890 Nanomicelles JO - Pharmaceutical Development and Technology VL - 24 IS - 2 SP - 133 EP - 144 PY - 2019 ER - |